论文部分内容阅读
目的观察脑出血后遗症患者临床治疗应用长春西丁的疗效。方法对100例脑出血后遗症患者随机分成治疗组和对照组,治疗组用长春西丁加常规治疗,对照组用常规治疗,在治疗了3周、6周以后欧洲脑卒中评分(ESS)增分率统计学分析,来观察判断治疗组和对照组的不同,以及治疗效果。结果治疗3周、6周以后治疗组ESS比对照组有明显的增高;6周时治疗组显效率及总有效率显著高于对照组(P<0.05),而且不良反应不明显。结论治疗脑出血后遗症使用长春西丁能显著提高基本治疗率。
Objective To observe the curative effect of vinpocetine in clinical treatment of patients with cerebral hemorrhage sequelae. Methods 100 patients with sequelae of cerebral hemorrhage were randomly divided into treatment group and control group. The treatment group was treated with vinpocetine plus conventional therapy while the control group was treated with conventional therapy. After 3 and 6 weeks of treatment, the European stroke score (ESS) score Rate of statistical analysis, to judge the treatment group and control group to determine the difference, and the treatment effect. Results After 3 weeks and 6 weeks of treatment, the ESS of the treatment group was significantly higher than that of the control group. At 6 weeks, the effective rate and total effective rate of the treatment group was significantly higher than that of the control group (P <0.05), and the adverse reaction was not obvious. Conclusion The treatment of cerebral hemorrhage sequelae with vinpocetine can significantly improve the basic treatment rate.